tiprankstipranks
Trending News
More News >

Ashwani Verma Profile - UBS Analyst

60 Followers
tipranks
Ashwani Verma

Ashwani Verma
UBS

Wall Street Analyst
#5,556 out of 9,867 Wall Street Analysts
#15,054 out of 41,403 experts

Success Rate

40%
38 out of 94 ratings made a profit

Average Return

+0.80%
Average return per rating
Time Frame
1 Year
Compare to
No Benchmark
Copying Ashwani Verma's trades since 2019 and holding each position for 1 Year would result in 40.43% of your transactions generating a profit, with an average return of 0.8% per rating.

Stock Rating Distribution

140Ratings
66.43% Buy
28.57% Hold
5.00% Sell
Distribution of Ashwani Verma's ratings

Additional Information

Main Sector:General
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Arcellx, Inc.
(ACLX)
Rating:Buy
Date:Oct 17, 2023 - Oct 17, 2024
Return:+170.90%
The most profitable rating made by Ashwani Verma

Ashwani Verma's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
RVNC
Revance Therapeutics
Feb 28, 2019
Buy
Reiterated
$29.00
(694.52%Upside)
1Ratings
100%
+36.40%
Rani Therapeutics Holdings
Oct 11, 2022
Buy
Initiated
$15.00
(2228.11%Upside)
1Ratings
0%
-75.50%
HZNP
Horizon Therapeutics
Nov 03, 2022
Hold
Reiterated
4Ratings
0%
-18.40%
Viatris
Oct 20, 2023
Hold
Reiterated
$11.00
(17.27%Upside)
3Ratings
0%
-1.70%
KRTX
Karuna Therapeutics
Jan 02, 2024
Hold
Reiterated
3Ratings
0%
-2.50%
Biohaven Ltd.
Apr 23, 2024
Buy
Reiterated
$60.00
(312.09%Upside)
2Ratings
0%
-31.75%
Arcellx Inc
Dec 10, 2024
Buy
Reiterated
$114.00
(67.91%Upside)
2Ratings
50%
+77.40%
Avadel Pharmaceuticals
Jan 11, 2025
Buy
Reiterated
$14.00
(45.99%Upside)
4Ratings
25%
-19.60%
ITCI
Intra-Cellular Therapies
Feb 05, 2025
Hold
Reiterated
$132.00
(0.10%Upside)
9Ratings
100%
+25.32%
Axsome Therapeutics
Feb 11, 2025
Buy
Reiterated
$133.00
(19.44%Upside)
7Ratings
50%
-25.43%
List of latest recommendations made by Ashwani Verma. Click to expand and see Ashwani Verma's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Advertisement
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

Ashwani Verma activity FAQ

What is the performance of Ashwani Verma's recommendations?
The percentage of profitable recommendations made by Ashwani Verma is 40%, and the average return per transaction is 0.80%.
    What stocks does Ashwani Verma cover?
    Ashwani Verma mostly covers TEVA , NBIX , JAZZ stocks.
      What was Ashwani Verma's most profitable rating?
      Ashwani Verma’s most profitable ratings was a buy on ACLX stock on Oct 17, 2023 - Oct 17, 2024. The return on the trade was +170.90%.
        Where can I see a list of stock analyst ratings?
        You can see a list of daily stock analyst ratings here.
          What are the most recommended stocks by analysts?
          You can see a list of the most recommended stocks by analysts here